Summary:
Summary Statement of Deficiencies D0000 The laboratory was surveyed and found to be in compliance with the Conditions of the CLIA regulations found at 42 CFR 493.1 through 493.1780, and recertification is recommended. D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. This STANDARD is not met as evidenced by: Based on review of the laboratory's records, interview, and pre-survey paperwork, the laboratory failed to retain the chemical name and concentration (if applicable), manufacturer, lot number, received date, and open date of the chemicals and stains used in the frozen section histopathology laboratory for the Hematoxylin and Eosin (H&E) and Diff Quik stains for 11 of 11 months reviewed. Findings follow. A. Review of the Frozen Section Lab QA and Supply Check List reviewed from March 2023 - January 2024 listed reagents and expiration dates. A reagent log with the manufacturer, lot number, received date, and open date of the chemicals and stains was requested on January 24, 2024 at 1120 hours but not provided. B. Interview with the Clinical Service Manager on January 24, 2024 at 1135 hours confirmed the laboratory did not maintain a reagent log. C. Review of the CMS Form 116 showed approximately 8 cases were reported in 2023. D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on review of patient test reports, interview, and pre-survey paperwork, the laboratory failed to include the name and address of the facility where the macroscopic examination (grossing), frozen sections, and touch preps were performed for four of five reports reviewed. Findings follow. A. Review of five test reports showed four were missing the name and address of the facility where the testing occurred: Date of Service Accession # Reported 1. 09/13/2023 AT23-007708 Macroscopic examination, frozen section diagnosis 2. 10/04/2023 AT23-008445 Macroscopic examination 3. 10/13/2023 AT23-008770 Macroscopic examination and frozen section diagnosis 4. 10/13/2023 AT23-008771 Macroscopic examination and frozen section diagnosis B. Interview with the Clinical Service Manager on January 24, 2024 at 1215 hours confirmed the test reports did not have the name and address of the facility for testing performed at the surgery center. C. Review of the CMS Form 116 showed approximately 8 cases were reported in 2023. -- 2 of 2 --